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Objectives: This study investigates the effects of controlled reoxygenation cardiopulmonary bypass on oxidative
stress, inflammatory response, and organ function in children undergoing repair of cyanotic congenital heart
defects.
Methods: Sixty-seven cyanotic patients (median age 15 months, interquartile range 6–49 months) undergoing
corrective cardiac surgery were randomized to receive either controlled normoxic (50–0 mm Hg; n ¼ 35) or hy-
peroxic (150–180 mmHg; n¼ 32) cardiopulmonary bypass. Troponin I and 8-isoprostane, C3a, interleukins 6, 8,
and 10, cortisol, protein S100, and alpha-glutamate transferase were measured preoperatively and 10 and 30 min-
utes after starting bypass, on removal of the aortic crossclamp, and 12 and 24 hours thereafter.
Results: Overall, troponin I and 8-isoprostane levels were lower in the controlled normoxic group (29%, 95%
CI48% to3%, P ¼ .03, and26%, 95% CI44% to2%, P ¼ .03, respectively). Protein S100 release was
also lower in the normoxic group 10 minutes after starting bypass (26%, 95% CI40% to9%, P¼ .005) and
10 minutes after aortic crossclamp removal (23%, 95% CI38% to3%, P ¼ .02, respectively), but similar at
other time points in the two groups (P  .17). The alpha-glutamate transferase release was significantly lower in
the normoxic group 10 minutes after aortic crossclamp removal (28%, 95% CI44% to9%, P¼ .006, respec-
tively) but was similar at other times (P .11). Release of C3a, interleukins 6, 8, and 10, and cortisol was similar
in the two groups throughout (P  .15).
Conclusion: Controlled reoxygenation on starting cardiopulmonary bypass is associated with reduced myocar-
dial damage, oxidative stress, and cerebral and hepatic injury compared with hyperoxic bypaass and similar whole
body inflammatory and stress response in cyanotic children undergoing open cardiac surgery.Repair of heart defects causing cyanosis is performed with
cardiopulmonary bypass (CPB) in early age with increasing
frequency. Postoperative cardiac dysfunction is the major
cause of morbidity and mortality despite successful surgical
correction.1,2 There is substantial experimental evidence for
the existence of a myocardial reoxygenation injury in the
cyanotic, immature heart. Studies of hypoxemia/reoxygena-
tion in immature piglets have provided evidence for oxygen-
mediated myocardial injury as a result of hyperoxemia in the
setting of previous cyanosis.3,4 We5 have shown that cya-
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and poorer clinical outcomes than do acyanotic ones after
similar periods of ischemic cardioplegic arrest. More re-
cently, we6 have shown that reintroduction of high oxygen
levels to cyanotic patients supported by CPB leads to myo-
cardial damage before ischemic cardioplegic arrest, suggest-
ing a CPB-induced mechanism of reoxygenation injury.
Hypoxia and reoxygenation have also emerged in recent
years as very important mechanisms of cerebral and hepatic
injury.7,8 Matheis and associates,9 in a small, observational
study, demonstrated that uncontrolled hyperoxic reoxygena-
tion on CPB for surgical correction of congenital heart de-
fects was associated with higher S100 levels in cyanotic
infants as compared with acyanotic patients undergoing
comparable operations, while hepatic reoxygenation injury
has been demonstrated in experimental animal models.10
Overall, these experimental and clinical studies provide
direct evidence that an unintended reoxygenation injury oc-
curs in cyanotic patients with the initiation of CPB, resulting
in organ damage. We hypothesized that controlling reoxyge-
nation during CPB could prevent the deleterious effect of
hyperoxic CPB on organ function. This randomizedrgery c July 2009
P
M
Caputo et al Perioperative ManagementAbbreviations and Acronyms
aGT ¼ alpha-glutathione S-transferase
C3a ¼ complement activation
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
EIA ¼ enzyme immunosorbent assay
FIO2 ¼ forced expiratory volume in 1 second
controlled trial, therefore, investigates the effects of con-
trolled normoxic (50–80 mm Hg) and relatively hyperoxic
(150–180 mm Hg) CPB on oxidative stress, inflammatory
response, and organ damage in infants and children under-
going repair of cyanotic congenital heart defects.
PATIENTS AND METHODS
Sixty-seven cyanotic patients undergoing corrective cardiac surgery be-
tween January 2003 and November 2006 at the Bristol Royal Hospital for
Children were randomized to receive either controlled normoxic (50–80
mm Hg) or hyperoxic (150–180 mm Hg) CPB. All patients were in a stable
condition without preoperative respiratory or inotropic support. ‘‘Nor-
moxia’’ referred to a pump prime, the PO2 of which is matched to the PO2
of the patient (ie, normoxic for the patient). ‘‘Hyperoxia’’ referred to
a pump prime prepared to the current ‘‘best practice’’ protocol, which has
a PO2 relatively hyperoxic for a cyanotic patient. The study was approved
by the Research Ethics Committee of the Bristol Royal Hospital for Chil-
dren and parental informed consent was gained for all patients. Treatment
allocations, stratified by age (<6 months vs 6 months), were generated
by computer in advance of starting the study, using block randomization
with varying block sizes. Allocation details were concealed in sequentially
numbered, opaque sealed envelopes. After consent was obtained the night
before the operation, a patient was randomly assigned from the next num-
bered envelope. The surgical team, except for the perfusionists, was blind
to the treatment allocation.
CPB, Anesthetic, and Surgical Technique
All operations were performed with CPB. Intraoperative anesthetic and
operative techniques were standardized as previously reported.11 However,
in the normoxic group, induction of anesthesia was started with a forced ex-
piratory volume in 1 second (FIO2) of 21% and in the hyperoxic group with
an FIO2 of 50%. Continuous pulse oximetry was used in every patient from
the start of anesthesia.
Cold blood (4C–6C) St Thomas Hospital I–based cardioplegic solu-
tion (4:1 dilution blood/St Thomas Hospital I crystalloid cardioplegic solu-
tion) was used for myocardial preservation, with the following composition
(mmol/L): 16 MgCl2, 2 CaCl2, 20 KCl, 147 NaCl, and 1.0 procaine HCl.
Additional cardioplegic solution was administered after each 20 minutes
of aortic crossclamping.
After the operation, all patients were admitted to the pediatric intensive
care unit and were managed according to unit protocols5,11 by intensivists
and pediatric cardiologists blinded to the treatment allocation.
The reoxygenation strategy on starting CPB was developed at our De-
partment of Clinical Perfusion Science as follows:
Normoxic CPB group. The CPB circuit is set up and primed as per
protocol,5,6 usually with a red blood cell/albumin prime or occasionally
a clear prime, depending on the patient’s hemoglobin level. Just before
the initiation of CPB, medical nitrogen is delivered to the gas exchange de-
vice (oxygenator) via a bacteriologic filter (0.2 mm) at a rate of between 100
and 200 mL/min while the prime is circulated at approximately 1000 mL/The Journal of Thoracic and Cmin. An in-line PO2 monitor is used to measure the PO2 of the prime (in
air this will equilibrate at roughly 150 mm Hg). Using this technique, we
are able to reduce the PO2 of the prime fluid to less than 100 mm Hg and
actually match that of the patient’s own (cyanotic) arterial PO2 levels. Fi-
nally, before CPB has been established, the prime PO2 is confirmed using
a point of care blood gas analyzer, and the in-line PO2 monitor is calibrated.
CPB is initiated in this ‘‘iso-oxic’’ manner and the PO2 levels of the arteri-
alized blood are adjusted accordingly during CPB, terminating CPB with an
arterial PO2 of between 100 and 110 mm Hg.
Hyperoxic CPB group. Oxygen delivery is run at 100% to keep ar-
terial oxygen saturation greater than 95% and PO2 levels between 150 and
180 mm Hg on starting CPB.
Outcome Variables
The primary end points were the release of troponin I (enzyme-linked im-
munosorbent assay; Access Immunoassay System; Beckman Instruments
Inc, Fullerton, Calif) and 8-isoprostane (enzyme immunoassay [EIA]; Cay-
manChemicals, AnnArbor,Mich) asmeasurements ofmyocardial cell dam-
age and oxidative stress, and the release of markers of the whole body
inflammatory response (complement activation [C3a] and interleukin [IL]
6, IL-8, and IL-10) (enzyme-linked immunosorbent assay; Amersham Bio-
sciences UK, Little Chalfont, United Kindom), and stress response (cortisol;
Access Immunoassay System, Beckman Coulter). Cerebral injury was assed
by the postoperative release of protein S100 (CanAg S100 EIA; CanAg Di-
agnosticsAB,Goteborg, Sweden) and alpha-glutathioneS-transferase (aGT)
(Biotrin High Sensitivity AlphaGST EIAAssay; Biotrin International, Dub-
lin, Ireland)was used to assess hepatic cell damage. Blood (5mL)was drawn
preoperatively, at 10 and 30 minutes after starting CPB, and 10 minutes, 12,
and24hours after comingoffCPB. Thiswas immediately centrifugedat 4C,
at 4000 rpm for 15 minutes. The resulting plasma was then frozen in liquid
nitrogen before storage at80C. The assays were performed by a laboratory
technician blinded to the treatment allocation and clinical status of the patient.
Clinical outcomes (duration of inotropic support after surgery, intubation
time, intensive care unit stay, postoperative hospital stay)were also recorded.
The sample size was calculated on the basis of previous similar studies car-
ried out at our institution inwhich statistically significant reductions in tropo-
nin I release (effect size 0.48) and in 8-isoprostane (effect size 0.94) were
found with 55 and 42 patients, respectively.11 With one preoperative and
five postoperative measurements, a sample size of 32 per group has 90%
power to detect effect sizes of .5 or more for both markers at the 5% level
of statistical significance (2-tailed) assuming a correlation of .7 between pre-
operative and postoperative values and between postoperative measures.
Statistical Analysis
Continuous outcomes are summarized as an arithmetic mean and stan-
dard deviation if normally distributed or as a geometric mean or median
and interquartile range if skewed. Categorical data are presented as actual
counts and percentages. Operative and postoperative characteristics
TABLE 1. Baseline characteristics
Variable Normoxic (n ¼ 35) Hyperoxic (n ¼ 32)
Age (m, median [IQR]) 15.0 (6.0–47.0) 14.5 (5.0–51.0)
Male (%) 22 (63) 18 (56)
Weight (kg, median [IQR]) 9.6 (7.5–13.9) 9.5 (6.6–15.8)
Renal failure (%) 2 (6) 3 (9)
Pathology (%)
Single ventricle physiology 14 (40) 13 (41)
TOF 14 (40) 14 (44)
TAPVD and TGA 7 (20) 5 (16)
Not all percentages sum to exactly 100% due to rounding. IQR, Interquartile range;
TOF, tetralogy of Fallot; TAPVD, total anomalous pulmonary venous defect; TGA,
transposition of the great arteriesardiovascular Surgery c Volume 138, Number 1 207
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Variable Normoxic (n ¼ 35) Hyperoxic (n ¼ 32) Effect size (95% CI) P value
Operative details
Oxygen saturation (mm Hg)* 79.9 (7.61) 78.5 (7.22) 1.34z (2.29 to 4.97) .46
Bypass time (min)y 82.9 (41–147) 89.7 (43–210) 0.93x (0.77 to 1.11) .40
Crossclamp time (min)* 52.0 (20.52) 52.3 (24.66) 0.39z (14.16 to 13.38) .96
Postoperative details
Ventilation time (min)y 21.5 (2–191) 19.6 (3–72) 1.12x (0.67 to 1.87) .66
Length of stay (d)(median [IQR]) 10.5 (6.0–14.0) 8.5 (6.5–12.5) 0.90k (0.55 to 1.50) .67
Dopamine
Coming off bypass (mg $ kg1 $ min1) 6.3 (3.44) 6.8 (4.84) 0.53z (2.61 to 1.56) .62
Peak dose (mg $ kg1 $ min1)* 11.8 (5.22) 9.6 (5.36) 2.19z (0.58 to 4.96) .12
Duration (h)y 33.5 (6–256) 28.6 (0–366) 1.19x (0.73 to 1.96) .48
Epinephrine (No. [%]) 2 (6) 4 (14)
CI, Confidence interval; IQR, interquartile ratio. *Values are expressed as mean (SD). yValues are expressed as geometric mean with range. zDifference in means (normoxic
hyperoxic). xRatio of geometric means (normoxic/hyperoxic). kHazard ratio for hospital discharge (normoxic/hyperoxic).measured on a continuous scale were compared by regression analysis ad-
justing for age. Skewed measures were log-transformed to achieve normal-
ity and the results were back transformed to the original scale. Biochemical
markers measured at multiple time points were analyzed with a mixed re-
gression model. All the markers had skewed distributions and were ana-
lyzed on the logarithmic scale. These analyses were adjusted for age,
baseline response, pathology, and the interactions between pathology and
time and treatment and time. Interactions between treatment and pathology
were investigated and, if statistically significant at the 5% level, the interac-
tion term was retained in the model.
Differences with respect to pathology and age are not reported explic-
itly; estimates are pooled over pathologies and age. Effect sizes are re-
ported as mean differences (if normally distributed) or as ratios of
geometric means (if skewed) with corresponding 95% confidence intervals
(CIs) and P values. If the treatment effect was consistent across time
points, an overall estimate, pooled over all time points, is reported; other-
wise the treatment effect is reported for each time point separately. Length
of stay was compared by Cox regression with the effect size being reported
as a hazard ratio for hospital discharge with its 95% CI. Categorical out-
comes were not subject to statistical analysis owing to the small number of
events (<10).
The authors had full access to the data and take responsibility for its in-
tegrity. All authors have read and agree to the manuscript as written.
RESULTS
Thirty-five patients were randomized to the normoxic and
32 to the hyperoxic CPB group. Overall, the median age was
15months (interquartile range 6–49months)with 60%male.
Reasons for surgery included tetralogy of Fallot (42%), sin-
gle ventricle (40%), and transposition of the great arteries
(12%). Preoperative characteristics are shown in Table 1. In-
traoperative and clinical outcomes are reported in Table 2.
Troponin I and 8-Isoprostane Release
Troponin I was released in a time-dependent fashion as
previously described11,12 (Figure 1, A). By 10 minutes after
the release of the aortic crossclamp, troponin levels were sig-
nificantly higher than baseline in both groups (Table 3). The
levels continued to rise during the 12 hours after surgery and
remained high (compared with baseline) at 24 hours. Over-
all, troponin I levels were significantly higher in the hyper-208 The Journal of Thoracic and Cardiovascular Suroxic group (ratio [normoxic/hyperoxic] ¼ 0.71, 95% CI
0.52–0.97, P ¼ .03).
The release of 8-isoprostane was also time dependent
(Figure 1, B). In both groups, levels rose significantly
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FIGURE 1. A, Time-related plasma changes in the geometric mean tropo-
nin I in the hyperoxic () and normoxic (-) groups. B, Time-related plasma
changes in the geometric mean 8-isoprostane in the hyperoxic () and nor-
moxic (-) groups. CPB, Cardiopulmonary bypass; SE, standard error.gery c July 2009
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Geometric mean*
Variable Time Normoxic Hyperoxic Ratio (95% CI) P value
Troponin I (n ¼ 32) (n ¼ 30)
Preop 0.03 0.02
10 min on CPB 0.3 0.5 0.63
30 min on CPB 0.8 1.3 0.67
10 min 6.4 9.9 0.65
4 h 7.5 10.3 0.73
24 h 5.4 6.0 0.91
Test for interaction between treatment and time .61
Treatment effect, pooled over all time points 0.71 (0.52–0.97) .03
8-Isoprostane (n ¼ 34) (n ¼ 30)
Preop 2.8 2.3
10 min on CPB 6.4 9.1 0.71
30 min on CPB 7.6 10.6 0.72
10 min 7.3 10.1 0.72
4 h 3.9 4.3 0.90
24 h 1.9 2.7 0.68
Test for common ratio .73
Treatment effect, pooled over all time points 0.74 (0.56–0.98) .03
IL-6 (n ¼ 34) (n ¼ 32)
Preop 0.7 0.5
10 min on CPB 0.9 1.0 0.90
30 min on CPB 1.1 1.1 1.02
10 min 4.7 5.9 0.80
4 h 37.6 43.7 0.86
24 h 58.5 51.7 1.13
Test for interaction between treatment and time .72
Treatment effect, pooled over all time points 0.94 (0.66–1.33) .71
IL-8 (n ¼ 34) (n ¼ 32)
Preop 5.2 4.5
10 min on CPB 7.1 7.4 0.95
30 min on CPB 8.1 9.0 0.90
10 min 16.7 18.1 0.92
4 h 36.7 32.2 1.14
24 h 29.0 27.3 1.06
Test for interaction between treatment and time .72
Treatment effect, pooled over all time points 0.99 (0.83–1.18) .93
IL-10 (n ¼ 34) (n ¼ 32)
Preop 9.3 11.2
10 min on CPB 12.8 17.8 0.72
30 min on CPB 15.0 22.4 0.67
10 min 89.9 145.1 0.62
4 h 89.6 105.7 0.85
24 h 26.5 30.0 0.89
Test for interaction between treatment and time .67
Treatment effect, pooled over all time points 0.74 (0.49–1.12) .15
C3a (n ¼ 34) (n ¼ 32)
Preop 1416.7 1357.7
10 min on CPB 1247.4 1254.0 0.99
30 min on CPB 1181.7 1467.0 0.81
10 min 1663.4 1843.1 0.90
4 h 1295.6 1462.2 0.89
24 h 1029.1 977.6 1.05
Test for interaction between treatment and time .16
Treatment effect, pooled over all time points 0.92 (0.82–1.04) .18The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 1 209
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Geometric mean*
Variable Time Normoxic Hyperoxic Ratio (95% CI) P value
Cortisol (n ¼ 29) (n ¼ 28)
Preop 485.6 410.2
10 min on CPB 255.2 262.1 0.97
30 min on CPB 255.8 288.4 0.89
10 min 216.1 261.6 0.83
4 h 157.4 204.5 0.77
24 h 368.4 297.3 1.24
Test for interaction between treatment and time .25
Treatment effect, pooled over all time points 0.93 (0.76–1.13) .45
S100 (n ¼ 33) (n ¼ 32)
Preop 226.4 229.5
10 min on CPB 355.7 481.0 0.74 (0.60–0.91) .005
30 min on CPB 668.6 695.3 0.96 (0.78–1.18) .71
10 min 1244.1 1610.0 0.77 (0.62–0.97) .02
4 h 327.0 368.0 0.89 (0.75–1.05) .17
24 h 228.3 217.8 1.05 (0.80–1.37) .73
Test for interaction between treatment and time .004
aGT (n ¼ 33) (n ¼ 32)
Preop 3683.7 3810.1
10 min on CPB 3235.4 3830.7 0.84 (0.69–1.04) .11
30 min on CPB 4093.3 4166.0 0.98 (0.82–1.18) .85
10 min 6797.4 9496.7 0.72 (0.56–0.91) .006
4 h 7423.5 8966.9 0.83 (0.60–1.15) .26
24 h 3097.0 3943.4 0.79 (0.58–1.07) .12
Test for interaction between treatment and time .02
CI, Confidence interval; CPB, cardiopulmonary bypass; IL, interleukin; C3A, complement component 3a; aGT, alpha-glutathione S-transferase. *Geometric means for measure-
ments during and after surgery are least squares estimates after adjusting for the preoperative values, age strata, pathology, the interaction between pathology and time and the
interaction between treatment and pathology (where appropriate, see Statistical Methods section for further details).from baseline 10 minutes after the start of CPB and remained
high 10 minutes after the release of the aortic crossclamp, af-
ter which time levels declined. The pattern of response was
the same in both groups. Throughout, 8-isoprostane levels
were significantly higher in the hyperoxic group. On aver-
age, 8-isoprostane levels were 35% higher in the hyperoxic
group (ratio ([normoxic/hyperoxic] ¼ 0.74, 95% CI 0.56–
0.98, P¼ .03). In addition, there was no evidence to suggest
time-related differences between the two groups (P ¼ .62).
Protein S100 and aGT
The protein S100 and aGT responses were also time de-
pendent (Table 3, Figure 2, A and B), but in contrast to the
other markers the difference between the hyperoxic and nor-
moxic groups varied with time (P ¼ .004 and P ¼ .02, re-
spectively). For protein S100, there was a significant
difference between the normoxic and hyperoxic groups after
10 minutes on CPB (ratio [normoxic/hyperoxic] ¼ 0.74,
95% CI 0.60–0.91, P¼ .005) and 10 minutes after stopping
CPB (ratio [normoxic/hyperoxic] ¼ 0.77, 95% CI 0.62–
0.97, P¼ .02), but at other time points the response was sim-
ilar (P .17). The mean aGT was also significantly lower in210 The Journal of Thoracic and Cardiovascular Surthe normoxic group 10 minutes after stopping CPB (ratio
[normoxic/hyperoxic] ¼ 0.72, 95% CI 0.56–0.91, P ¼
.006), but at other time points the levels were similar in
the two groups (P  .12).
Release of Inflammatory Markers (IL-6, IL-8, IL-10,
C3a, and Cortisol)
The release of the inflammatory markers IL-6, IL-8, IL-
10, C3a, and cortisol was also time dependent (Table 3,
Figures 3 to 5). In both groups, IL levels rose significantly
after the release of the aortic crossclamp and remained sig-
nificantly higher than at baseline. The C3a profile was
thereafter similar to that for the ILs; the response was great-
est 10 minutes after the release of the aortic crossclamp,
then declined, and by 24 hours was lower than at baseline.
In contrast, cortisol levels fell dramatically during surgery
and remained lower than at baseline thereafter. For all
five inflammatory markers, there was no evidence to sug-
gest time-related differences between the two groups (P
 .16), and in all cases the response for children in the hy-
peroxic group was similar to that for the normoxic group
(P  .18, Table 3).gery c July 2009
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This study demonstrates that ‘‘controlled reoxygenation’’
on starting CPB in cyanotic patients undergoing cardiac sur-
gery significantly reduces reoxygenation injury. Normoxic
CPB was indeed associated with reduced oxidative stress,
myocardial, cerebral, and hepatic injury, and similar whole
body inflammatory and stress response compared with hy-
peroxic CPB.
Myocardial Damage and Reoxygenation Injury
One of the strategies proposed to avoid reoxygenation in-
jury is the use of controlled reoxygenation during CPB. Al-
len and associates13 demonstrated an improvement in the
antioxidant reserve capacity with lower levels of oxygen
in cyanotic infants undergoing cardiac surgery, and similar
findings were obtained by Bulutcu and coworkers.14 Our re-
sults confirm these findings and further stress the importance
of controlled reoxygenation on starting CPB in cyanotic
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FIGURE 2. A, Time-related plasma changes in the geometric mean protein
S100 in the hyperoxic () and normoxic (-) groups. B, Time-related plasma
changes in the geometric mean alpha-glutathione S-transferase (aGT) in the
hyperoxic () and normoxic (-) groups. CPB, Cardiopulmonary bypass;
SE, standard error.The Journal of Thoracic and Cpatients. The perfusion strategy of keeping PO2 as close as
possible to the patient’s preoperative values resulted in a
reduced oxidative stress and myocardial cell damage. Reox-
ygenation injury is associated with the production of reactive
oxygen species by the formation of oxygen-derived free rad-
icals such as superoxide and peroxide. This leads to cell
membrane degradation through lipid peroxidation.15,16 It is
now evident that oxidative stress is a major part of the cellu-
lar mechanism of the resulting myocardial damage.17-20
8-Isoprostane has been shown to be a reliable marker for
the volume of myocardium exposed to oxidant stress during
acute myocardial infarction17,20 as well as a quantitative
marker of oxidant stress during coronary reperfusion.19
The increased 8-isoprostane levels in the hyperoxic group
were also associated with higher troponin I release, suggest-
ing a direct effect of CPB oxygen levels on the degree of
reperfusion injury.
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FIGURE 3. A, Time-related plasma changes in the geometric mean inter-
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In this randomized trial, we found that controlling reoxy-
genation 10 minutes after the initiation of CPB was associ-
ated with significant increase of protein S100 release with
values that returned to preoperative levels in both groups
24 hours after the operation. In support of our data is the clin-
ical evidence of the effects of reoxygenation injury on cere-
bral function reported byMatheis and colleagues9 in a small,
observational study. The authors demonstrated that uncon-
trolled hyperoxic reoxygenation on CPB for surgical correc-
tion of congenital heart defects was associated with higher
S100 levels in cyanotic infants compared with acyanotic pa-
tients undergoing comparable operations.
In recent years, hypoxia and reoxygenation have emerged
as very important mechanisms of cerebral injury. Indeed,
Sher and Hu7 demonstrated in an in vitro cell model that
gradual reoxygenation after prolonged hypoxia improves
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FIGURE 4. A, Time-related plasma changes in the geometric mean inter-
leukin 10 (IL-10) in the hyperoxic () and normoxic (-) groups. B, Time-
related plasma changes in the geometric mean C3a in the hyperoxic () and
normoxic (-) groups. CPB, Cardiopulmonary bypass; SE, standard error.212 The Journal of Thoracic and Cardiovascular Suneuronal survival compared with rapid reoxygenation and
delays the manifestations of metabolic dysfunction. Their
findings are also consistent with the concept that a period
of relative hyperoxia may contribute to hypoxia-induced
neuronal injury. Similarly, Stauton and coworkers8 have
shown that hypoxemia–reoxygenation causes endothelial
dysfunction in intraparenchymal cerebral arterioles by im-
pairing endothelium-dependent dilation of microvessels,
which in turn may decrease oxygen delivery and increase
neuronal injury. The use of protein S100 beta release as
a marker of cerebral injury remains controversial inasmuch
as it has been shown to be affected by potential contamina-
tion from sources such as bypass suckers and mediastinal
fat.21 However, protein S100 is still considered one of the
most specific and sensible markers of cerebral injury after
cardiac surgery and is widely used in clinical trials.22 Fur-
thermore, we23 have shown that there is a close correlation
between S100 release and retinal embolization in patients
undergoing coronary surgery.
Hepatic Injury
Hepatic reoxygenation injury has been demonstrated in
experimental animal models of rats undergoing induced hyp-
oxia for 60minutes followed by 25minutes of reflow.24 It has
also been shown that during reoxygenation of perfused rat
liver, there is an increased oxyradical production leading to
liver injury.10 The aGTs are a group of cytosolic proteins
that constitute up to 2% to 5% of the soluble protein in he-
patocytes.25 The baseline level of aGTs in serum is extremely
low, and as such it is easy to monitor any increases that may
occur. aGT is a very sensitive and specific biomarker of he-
patocyte injury.26 It is unaffected by muscle injury25 and
other factors that can cause elevated transaminase levels.
An elevated aGT level indicates hepatocyte injury even
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almost excludes acute hepatocyte injury.25
Our study shows that the aGT levels are similar in the two
groups during CPB but that there is a significant increase in
aGT concentration in the hyperoxic compared with the con-
trolled normoxic group immediately postoperatively. There-
after, the levels of aGT are similar in each group. To the best
of our knowledge, this represents the first clinical evidence
of a reduced hepatic injury when a strategy of controlled
reoxygenation CPB is adopted in cyanotic children undergo-
ing cardiac surgery.
Inflammatory and Stress Response
Our study shows that the inflammatory and stress re-
sponse triggered by CPB was similar in the hyperoxic and
normoxic groups. The pro-inflammatory cytokine levels
(IL-6 and IL-8) and cortisol increased significantly at the
end of the ischemic time and remained significantly elevated
after 24 hours, indicating the induction of a systemic inflam-
matory and stress response with either techniques of CPB.
This was also associated with a significant increase in C3a
at the end of the ischemic time, with subsequent decrease to-
ward preoperative levels after 24 hours. In addition to the
production of pro-inflammatory cytokines related to CPB,
our results clearly demonstrate significant secretion of the
anti-inflammatory cytokine IL-10. In contrast to the release
of IL-6 and IL-8, the pattern of IL-10 release showed a signif-
icant peak as early as 10 minutes after the end of the ische-
mic time and tended to return toward preoperative levels
after 24 hours.
These findings agree with the results of previously pub-
lished studies indicating similar time-related inflammatory
and stress response during pediatric cardiac surgical proce-
dures.27-30
Clinical Implication of the Study and Conclusion
This study provides direct evidence that an unintended
oxygen-mediated injury occurs in cyanotic patients with
the initiation of CPB, resulting in myocardial, cerebral,
and hepatic injury. This reoxygenation injury can be reduced
by using a novel and simple CPB strategy of controlled re-
oxygenation. This strategy is simple and can be incorporated
at no additional risk into the operative management, so long
as the perfusionist is familiar with the technique and the
equipment is appropriate. It does not interfere with the sur-
gical procedure and, by limiting oxidative stress and reoxy-
genation injury in this very high-risk group of patients,
might lead to a reduction in morbidity and mortality.
Our study cannot detect differences in clinical outcome
between the two groups; the primary outcomes were related
to differences in biochemical markers of organ dysfunction.
Recruitment to a larger trial to evaluate clinical outcomes as
primary end points is ongoing at our Institution.The Journal of Thoracic and CWe thank Mark Ginty and Svitlana Korolchuk for performing
the biochemical analyses, Professor A. Wolf, Mr. D Trivedi, the
Perfusion Department, and the pediatric nursing staff for their
support.
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